Supply Chain Intelligence

Integra LifeSciences Holdings Corporation Supply Chain

IART supply chain intelligence for Integra LifeSciences Holdings Corporation: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

IART ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

9Suppliers
15Customers
2Debt Items
20Related Chains

Integra LifeSciences Holdings Corporation Suppliers

TickerNameConfidenceEvidence
MDXG MiMedx Group, Inc. 72% Reciprocal relationship from MDXG graph: Reciprocal relationship from IART graph: Reciprocal relationship from MDXG graph: ls increase their purchases of our products during the fourth quarter to coi…
MDXG MiMedx Group, Inc. 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
ORGO Organogenesis Holdings Inc. 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
ORGO Organogenesis Holdings Inc. 72% Reciprocal relationship from ORGO graph: Reciprocal relationship from IART graph: rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitiv…
SMTI Sanara MedTech Inc. 72% Reciprocal relationship from SMTI graph: Reciprocal relationship from IART graph: Reciprocal relationship from SMTI graph: ting room etiquette and credentialing requirements. After completing their i…
SNNUF Smith & Nephew plc 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
SNNUF Smith & Nephew plc 72% Reciprocal relationship from SNNUF graph: Reciprocal relationship from IART graph: Reciprocal relationship from SNNUF graph: Reciprocal relationship from IART graph: rganization, our innovative techn…
STE STERIS plc 72% Reciprocal relationship from STE graph: Reciprocal relationship from IART graph: Reciprocal relationship from STE graph: Reciprocal relationship from IART graph: usiness, including the U.S. These ini…
STE STERIS plc 72% usiness, including the U.S. These initiatives put increased emphasis on the delivery of more cost-effective medical devices and therapies. Government programs, including Medicare and Medicaid, privat…

Integra LifeSciences Holdings Corporation Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-DEFENSE USGOV-DEPARTMENT-OF-DEFENSE 95% USAspending awards from Department of Defense: $85,694 across 2 awards. N0018924FZ272 IP2P BRAIN PROBE KITS; N0018925FZ586 IP2P BRAIN PROBE KITS | Qwen corrected direction: Explicit government contra…
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES 95% USAspending awards from Department of Health and Human Services: $88,210 across 1 awards. 75N90025P00591 25-007631 INTEGRA LIFESCIENCES CORPORATION CORDLESS HEADLIGHT SYSTEM AND BATTERIES | Qwen corr…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS 95% USAspending awards from Department of Veterans Affairs: $651,740 across 7 awards. 36C24625P1066 INTEGRA ULTRASONIC SURGICAL ASPIRATOR SYSTEM; 36C26325P0886 ENT SURGICAL SHAVER; 36C25023P0645 HIGHLY S…
MDXG MiMedx Group, Inc. 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
MDXG MiMedx Group, Inc. 72% Reciprocal relationship from MDXG graph: Reciprocal relationship from IART graph: rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitiv…
ORGO Organogenesis Holdings Inc. 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
ORGO Organogenesis Holdings Inc. 72% Reciprocal relationship from ORGO graph: Reciprocal relationship from IART graph: Reciprocal relationship from ORGO graph: Reciprocal relationship from IART graph: rganization, our innovative technol…
SMTI Sanara MedTech Inc. 72% Reciprocal relationship from SMTI graph: ting room etiquette and credentialing requirements. After completing their internal training, new hire field sales representatives participate in field traini…
SNNUF Smith & Nephew plc 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
SNNUF Smith & Nephew plc 72% Reciprocal relationship from SNNUF graph: Reciprocal relationship from IART graph: rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competiti…
STE STERIS plc 72% usiness, including the U.S. These initiatives put increased emphasis on the delivery of more cost-effective medical devices and therapies. Government programs, including Medicare and Medicaid, privat…
STE STERIS plc 72% Reciprocal relationship from STE graph: Reciprocal relationship from IART graph: usiness, including the U.S. These initiatives put increased emphasis on the delivery of more cost-effective medical de…
GENTELL-LLC GENTELL-LLC 62% Acquisition On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. (“SIA”) for an acquisition purchase price of $ 51.5 million (the “SIA Acquisition”) plus…
SURGICAL-INNOVATION-ASSOCIATES-INC SURGICAL-INNOVATION-ASSOCIATES-INC 62% easures. Governmental health systems have revised and continue to consider revisions of healthcare budgets, which could result in stricter standards for implementing certain medical procedures, incre…
TISSUE-TECHNOLOGIES TISSUE-TECHNOLOGIES 62% al (“CSS”) and Tissue Technologies (“TT”). The CSS segment, which represents approximately two-thirds of our total revenue, consists of market-leading technologies and instrumentation used for a wide…

Integra LifeSciences Holdings Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
IART-DEBT Debt stack $2.0B 90% Market cache reports total debt of $2.0B.
IART-DEBT-10158 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-12-31.

Integra LifeSciences Holdings Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Integra LifeSciences Holdings Corporation.

Integra LifeSciences Holdings Corporation Ownership

HolderNameConfidenceEvidence
IART-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 204 tracked holders.

Integra LifeSciences Holdings Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
JNJ Johnson & Johnson 100.00 2
TELA TELA Bio, Inc. 100.00 2
SMTI Sanara MedTech Inc. 100.00 1 ['customer', 'supplier']
NDRA ENDRA Life Sciences Inc. 100.00 2
NPCE NeuroPace, Inc. 100.00 2
PLSE Pulse Biosciences, Inc. 100.00 2
MDXG MiMedx Group, Inc. 100.00 1 ['customer', 'supplier']
ORGO Organogenesis Holdings Inc. 100.00 1 ['customer', 'supplier']
AURX Nuo Therapeutics, Inc. 100.00 2
PYPD PolyPid Ltd. 100.00 2
CUPR Cuprina Holdings (Cayman) Limited 100.00 2
IHG InterContinental Hotels Group PLC 100.00 2
EW Edwards Lifesciences Corporation 100.00 2
OBIO Orchestra BioMed Holdings, Inc. 100.00 2
DEO Diageo plc 100.00 2
MDWD MediWound Ltd. 100.00 2
GWW W.W. Grainger, Inc. 100.00 2
SSII SS Innovations International, Inc. 100.00 2
ISRG Intuitive Surgical, Inc. 100.00 2
XTNT Xtant Medical Holdings, Inc. 100.00 2
View IART supply chain intel →

Explore the full interactive supply chain map for Integra LifeSciences Holdings Corporation.

Open IART supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map